ArticleThe Lancet. Rheumatology2022

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease.

Clive KellyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.